Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Icodec + Semaglutide Combo Shows Benefit in Type 2 Diabetes
MADRID — Novo Nordisk’s investigational once-weekly combination of insulin icodec plus semaglutide (IcoSema) could benefit people with type 2 diabetes who don’t reach target glycemic goals with either single agent alone, new research suggests. Data for three 52-week multicenter randomized…
English